What is Thermo Fisher Scientific's revenue?

Thermo Fisher Scientific (TMO) generated $43.4B in revenue over the trailing twelve months, up 2.4% year over year.

Is Thermo Fisher Scientific profitable?

Thermo Fisher Scientific reported $6.8B in net income over the trailing twelve months, a 15.2% net margin.

What are Thermo Fisher Scientific's profit margins?

Gross margin is 58.3% and operating margin is 17.2%, with a 15.2% net margin.

What is Thermo Fisher Scientific's earnings per share?

Thermo Fisher Scientific's diluted EPS over the trailing twelve months is $18.19.

Where does Thermo Fisher Scientific's income statement data come from?

Every line is extracted from Thermo Fisher Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Thermo Fisher Scientific TMO Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	——	——	——	——	$42.9B0.0%
Research and development	——	——	——	——	$1.4B+0.8%
Selling, general and administrative	——	——	——	——	$8.49B-1.2%
Restructuring charges	——	——	——	——	——
Total costs & expenses	——	——	——	——	$35.51B-0.1%
Operating income	——	——	——	——	$7.39B+0.7%
Interest expense	——	——	——	——	$1.33B-4.3%
Interest income	——	——	——	——	$1B-7.1%
Income from equity method investments	——	——	——	——	——
Income before income taxes	——	——	——	——	$7.07B+0.4%
Income tax expense	——	——	——	——	$472M-28.3%
Net income	$6.85B+2.1%	$6.7B+2.0%	$6.57B-0.2%	$6.58B+1.1%	$6.52B+2.8%
Net income attributable to noncontrolling interests	——	——	——	——	——
Diluted earnings per share	$18.19+2.5%	$17.74+2.5%	$17.31+0.1%	$17.29+1.4%	$17.05+3.1%
Basic earnings per share	$18.22+2.5%	$17.77+2.5%	$17.34+0.1%	$17.32+1.3%	$17.09+3.1%
Weighted-average shares, diluted	1.5B-0.4%	1.5B-0.3%	1.5B-0.4%	1.5B-0.3%	1.5B-0.3%
Weighted-average shares, basic	1.5B-0.4%	1.5B-0.3%	1.5B-0.3%	1.5B-0.3%	1.5B-0.3%
Restructuring and Other Costs	——	——	——	——	$525M+21.8%
Restructuring and Related Costs (Non-cash)	——	——	——	——	——
Workforce Reduction Charges	——	——	——	——	——
Other Non-cash Income (Expense)	-$408M+10.3%	-$455M+20.0%	-$569M-3.6%	-$549M+6.9%	-$590M-16.1%
Foreign Rate Differential	——	——	——	——	——
Statutory Federal Income Tax Rate	——	——	——	——	——
Tax Reconciliation: Enacted Rate Change	——	——	——	——	——
Tax Reconciliation: Nondeductible Expenses	——	——	——	——	——
Tax Reconciliation: Other Adjustments	——	——	——	——	——
Tax Reconciliation: Tax Credits	——	——	——	——	——
Change in Tax Valuation Allowance	——	——	——	——	——
Share-based compensation expense related to employee stock plans	——	——	——	——	——
Amortization of capitalized software and acquired intangible assets	$1.73B+0.1%	$1.73B-0.1%	$1.73B-0.8%	$1.75B-4.6%	$1.83B-6.3%
Stock options excluded as their inclusion would be anti-dilutive (in shares)	——	——	——	——	——
Capital investments accrued but not yet paid	——	——	——	——	——
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	——	——	——	——	——
Dividends declared (in dollars per share)	——	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	——	——	——	——	——
Less: comprehensive income attributable to noncontrolling interest	——	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	——	——	——	——	——
Deferred taxes	——	——	-$930M+22.7%	-$1.2B—	——
Depreciation	$1.08B+2.9%	$1.05B-1.1%	$1.06B-5.6%	$1.13B-1.8%	$1.15B-0.8%
Dividends, Common Stock, Cash	——	——	——	——	——
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash	——	——	——	$250M+429%	-$76M+16.5%
Effective tax rates	——	——	——	——	——
Income taxes at U.S. statutory rate of 21%	——	——	——	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	——	——	——	——	——
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate	——	——	——	——	——
Effect of cross-border tax laws	——	——	——	——	——
Effect of cross-border tax laws	——	——	——	——	——
Foreign operations	——	——	——	——	——
Nontaxable or nondeductible items	——	——	——	——	——
State income taxes – net of federal income tax benefit	——	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——	——
Impairment Of Long Lived Assets Held For Use	——	——	——	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	——	——	——	——	——
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	——	——	——	——	——
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	——	——	——	——	——
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	——	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——	——
Increase Decrease In Operating Capital Excluding Deferred Taxes	——	——	——	——	——
Add - Incremental shares under stock-based compensation plans (in shares)	——	——	——	——	——
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders	——	——	——	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$3B+66.4%	$1.8B+133%	-$5.39B+9.4%	-$5.95B-17.3%	-$5.07B+25.3%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	——	——	-$4.94B-12.4%	-$4.39B-0.8%	-$4.36B+25.6%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$8.29B+6.0%	$7.82B+2.2%	$7.65B+1.0%	$7.58B-6.9%	$8.14B-6.1%
Net Income Loss Attributable To Noncontrolling Interest	——	——	——	——	——
Net Income Loss Attributable To Redeemable Noncontrolling Interest	——	——	——	——	——
Net loss	——	——	——	——	——
Number of reportable segments	——	——	——	——	——
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax	——	——	——	——	——
Other comprehensive items	——	——	——	——	——
Other Comprehensive Income (Loss), Net of Tax Including Portion Attributable to Redeemable and NonRedeemable Noncontrolling Interest	——	——	——	——	——
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax	——	——	——	——	——
Other Comprehensive Income Loss Reclassification Adjustment From AOCI Pension And Other Postretirement Benefit Plans Tax	——	——	——	——	——
Other Comprehensive Income Loss Reclassification Adjustment From AOCI Pension And Other Postretirement Benefit Plans Net Of Tax	——	——	——	——	——
Other Noncash Income (Expense)	-$408M+10.3%	-$455M+20.0%	-$569M-3.6%	-$549M+6.9%	-$590M-16.1%
Other income, net (Note 6)	——	——	——	——	$6M-53.8%
Payment for (Proceeds from) Other Investing Activity	$33M+257%	-$21M+8.7%	-$23M-109%	-$11M-22.2%	-$9M+47.1%
Payments for Repurchase of Common Stock	$4B+33.3%	$3B-24.3%	$3.96B—	——	——
Payments for Restructuring	——	——	——	——	——
Payments of Ordinary Dividends, Common Stock	$649M+2.0%	$636M+2.1%	$623M+2.1%	$610M+2.2%	$597M+2.4%
Payments to Acquire Businesses, Net of Cash Acquired	——	——	——	——	$3.13B0.0%
Payments to Acquire Investments	$133M-65.3%	$383M-77.2%	$1.68B-12.8%	$1.93B+1.4%	$1.9B-44.0%
Payments to Acquire Property, Plant, and Equipment	$1.54B+0.9%	$1.53B-1.0%	$1.54B+9.4%	$1.41B-0.5%	$1.42B+1.1%
Proceeds from Issuance of Commercial Paper	——	——	——	——	$0—
Debt issued (Note 13)	——	——	——	——	——
Proceeds from cross-currency interest rate swap interest settlements	$277M+3.4%	$268M+0.4%	$267M-2.9%	$275M0.0%	$275M+9.1%
Financing — other	——	——	——	——	$147M-30.7%
Proceeds from disposition of marketable securities and other investments	——	——	——	——	——
Dispositions of property, plant, and equipment	$41M-6.8%	$44M+29.4%	$34M-32.0%	$50M-23.1%	$65M+14.0%
Repayments of Long-Term Debt	$2.99B+23.8%	$2.41B-41.5%	$4.13B-21.2%	$5.23B+17.7%	$4.45B+23.2%
Foreign exchange and other	——	——	——	——	——
Revenue From Contract With Customer Excluding Assessed Tax	——	——	——	——	$42.9B0.0%
Property, plant, and equipment additions	——	——	——	——	——
Stock-based compensation	$318M+2.6%	$310M+1.6%	$305M+0.7%	$303M-1.0%	$306M+1.7%
Share Repurchase Program, Excise Tax	——	——	——	——	——
Stock Issued1	——	——	——	——	——
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture	——	——	——	——	——
Other – net	——	——	——	——	——
Treasury stock, value, acquired	——	——	——	——	——
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions	——	——	——	——	——
Cash Dividends, Common Stock	$649M+2.0%	$636M+2.1%	$623M+2.1%	$610M+2.2%	$597M+2.4%
Cash Flow Hedge Reclassification, After Tax	——	——	——	——	——
Comprehensive Income Attributable to Noncontrolling Interests	——	——	——	——	——
Comprehensive Income, Including Noncontrolling Interest	——	——	——	——	——
Currency Translation Adjustment, Net of Tax	——	——	——	——	——
Defined Benefit Plan Adjustment, After Tax	——	——	——	——	——
Other Comprehensive Income (Loss)	——	——	——	——	——
Amortization of Net Pension Loss, Net of Tax	——	——	——	——	——
Tax Benefit on Pension Amortization	——	——	——	——	——
Tax on Reclassification of Hedging Instruments	——	——	——	——	——
Tax on Pension Adjustment Before Reclassification	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Thermo Fisher Scientific.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Thermo Fisher Scientific's revenue?: Thermo Fisher Scientific (TMO) generated $43.4B in revenue over the trailing twelve months, up 2.4% year over year.
Is Thermo Fisher Scientific profitable?: Thermo Fisher Scientific reported $6.8B in net income over the trailing twelve months, a 15.2% net margin.
What are Thermo Fisher Scientific's profit margins?: Gross margin is 58.3% and operating margin is 17.2%, with a 15.2% net margin.
What is Thermo Fisher Scientific's earnings per share?: Thermo Fisher Scientific's diluted EPS over the trailing twelve months is $18.19.
Where does Thermo Fisher Scientific's income statement data come from?: Every line is extracted from Thermo Fisher Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.